On August 12th, Dr. Thomas Brooks was the first surgeon in Nebraska and among the first in the country to implant a patient with RestoreSensor SureScan MRI with Vectris SureScan MRI percutaneous leads. This device provides neurostimulation treatment that cuts off pain signals from reaching the brain, and this sort of treatment has become a mainstay of chronic pain management. What’s novel about this device is that it also allows patients to undergo full-body MRI scans while the device is still implanted. While MRI is a standard of care in the diagnosis and treatment of major health conditions, including cancer, stroke and neurological problems, patients with neurostimulation systems implanted to manage their chronic pain previously couldn’t get MRIs because of concerns about the system being affected by the large magnetic fields and radio frequency energy involved in MRI.

With a reputation for excellence, innovation and extraordinary patient care, The Nebraska Medical Center is ranked by U.S. News and World Report as one of America’s Top Hospitals in cancer, neurology/neurosurgery, orthopaedics, gastroenterology and nephrology. As the teaching hospital for the University of Nebraska Medical Center, this 627 licensed bed academic medical center has an international reputation for providing solid organ and bone marrow transplantation and is well known nationally and regionally for its oncology, neurology and cardiology programs.  The Nebraska Medical Center can be found online at www.nebraskamed.com.